• Who We Are
    • Vision
    • Our Story
      • Legacy gifts
    • Staff
    • Board of Directors
    • Contact Us & Directions
    • Financial Documents
  • What We Fund
    • Justice Initiatives
    • Strategic Initiatives
  • Who We Fund
    • Current Grants
    • Past Grants
  • What’s New
  • Publications
  • 30th Anniversary
HomeGrants2018An Integrative Approach to the Genetics and Genomics of ALS

Current Grants

Back

New York Genome Center, The

New York, NY

An Integrative Approach to the Genetics and Genomics of ALS

2018 - 2022

Founded in 2011 as a partnership of renowned academic, medical and industry leaders, the New York Genome Center (NYGC) focuses on translating genomic research into clinical solutions for serious disease. As part of this mission, NYGC is dedicated to understanding the relationship between DNA sequence variation and mechanisms for human diseases, including ALS. Funding from The Tow Foundation will support this effort by advancing the main goals of the Center for Genomics of Neurogenerative Disease at the NYGC. These goals include identifying mutations underlying neurodegenerative disease; integrating DNA sequence information with RNA sequencing data; developing a functional genomics program using mouse modes and IPS cell lines to understand the mechanistic basis of disease; create and maintain a publicly available data warehouse for ALS, DNA and RNA sequencing data; and conduct education and outreach including symposia, workshops and training.

For more information visit:
New York Genome Center
Medicine, New York
Back

Connect with The Tow Foundation

Directions & Contact

THE TOW FOUNDATION
50 Locust Avenue, Suite 1
New Canaan, CT 06840-4737

Website Flyleaf Creative and Medium Rare | Photography Richard Freeda